All Cosmos Bio-Tech Holding Corp.(TW:4148)
NT$29.40+0.20 (+0.68%)
TW:4148
All Cosmos Bio-Tech Holding Corp. financials statements
NT$29.40
At close:+0.20 (+0.68%)
All Cosmos Bio-Tech Holding Corp. (4148) Income Statement
All Cosmos Bio-Tech Holding Corp. Income Statement
Last quarter (Q2 2026), All Cosmos Bio-Tech Holding Corp.'s total revenue was NT$984.57M, an increase of 33.13% from the same quarter last year. In Q2, All Cosmos Bio-Tech Holding Corp.'s net income was NT$76.65M. See All Cosmos Bio-Tech Holding Corp.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 2.95B | NT$ 2.46B | NT$ 2.83B | NT$ 3.70B | NT$ 2.20B | |
| NT$ 829.47M | NT$ 668.59M | NT$ 587.98M | NT$ 1.14B | NT$ 594.37M | |
| NT$ 532.88M | NT$ 504.88M | NT$ 375.99M | NT$ 477.85M | NT$ 381.63M | |
| Depreciation and Amortization | NT$ 65.97M | NT$ 53.98M | NT$ 49.15M | NT$ 49.01M | NT$ 48.59M |
| NT$ 362.56M | NT$ 312.83M | NT$ 310.76M | NT$ 699.84M | NT$ 373.03M | |
| NT$ 296.59M | NT$ 155.88M | NT$ 189.90M | NT$ 645.50M | NT$ 265.62M | |
| NT$ 783.00K | NT$ 96.89M | NT$ 67.73M | NT$ -11.55M | NT$ 48.34M | |
| NT$ 297.37M | NT$ 252.77M | NT$ 257.63M | NT$ 633.95M | NT$ 321.58M | |
| NT$ 153.00M | NT$ 128.59M | NT$ 139.36M | NT$ 368.20M | NT$ 198.13M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 2.28 | NT$ 2.02 | NT$ 2.18 | NT$ 5.75 | NT$ 3.09 |
| Diluted EPS | NT$ 2.28 | NT$ 1.94 | NT$ 1.97 | NT$ 5.65 | NT$ 3.09 |
| Weighted Average Shares Outstanding | 90.45M | 64.03M | 64.03M | 64.03M | 64.03M |
| Weighted Average Shares Outstanding (Diluted) | 90.45M | 64.69M | 70.77M | 66.04M | 64.21M |
Currency in TWD

